Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feal Mycobiome Profiling Depending on Alcoholic Liver Disease Severity.

NCT05793190 is registered in ClinicalTrials.gov with Chuncheon Sacred Heart Hospital as lead sponsor.

NCT NCT05793190
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05793190 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feal Mycobiome Profiling Depending on Alcoholic Liver Disease Severity.
Lead sponsor
Chuncheon Sacred Heart Hospital
Phase
Observational
Overall status
Unknown status
Start date
April 15, 2021
Completion date
November 30, 2023
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcoholic liver disease